Patent Grant
12029652
This application is a national phase filing under 35 U.S.C. § 371 of International Application No. PCT/EP2018/066203 filed on Jun. 19, 2018, which claims benefit of priority from French Patent Application No. 1755562 filed Jun. 19, 2017, the contents of which are hereby incorporated by reference in their entirety.
The present invention relates to the general technical field of the ultrasonic devices for imaging and/or treating a human or animal brain tissue by ultrasounds in order to assist a practitioner in establishing a diagnosis and/or in order to treat a pathology.
Various techniques for imaging or treating a brain tissue are known.
1. Imaging
Brain imaging (or neuro-imaging) can be used to allow the practitioner to follow the progression of a brain injury or a brain tumor for diagnosis and/or surgical procedure purposes.
The most commonly used imaging techniques are the computed tomography (commonly called scanner) and the magnetic resonance imaging (MRI). Although these techniques are effective, they have disadvantages. In particular, the computed tomography is becoming less and less used because of the risks of neoplasia. The magnetic resonance imaging has a high cost and requires the injection of a contrast agent to the patient.
It is therefore desirable to have an alternative technique to enable brain imaging.
Imaging techniques based on the use of ultrasounds for imaging a brain tissue are also known. However, these techniques face the difficulty of transmitting ultrasounds through the cranium of the patient.
2. Treatment
Various techniques for treating a brain tissue, in particular by ultrasounds, are known.
Document EP 2 539 021 for example describes an apparatus for treating disorders of the brain comprising:
The operating principle of this apparatus is as follows. Once the ultrasonic device is implanted into the skull of the patient, a succession of treatment sessions are provided to the latter to treat the pathology affecting him. At each new treatment session, the intracorporeal device is connected to the control unit via the connection means.
Even if the apparatus described in document EP 2 539 021 enables an effective treatment of brain disorders, it would be desirable to have an alternative treatment technique for applying ultrasounds from outside the skull so as to simplify the work of the practitioner, the installation of the connection means between the ultrasonic device and the control unit can sometimes be difficult to implement.
In addition, an outer ultrasonic device can have the following advantages:
Other apparatuses for treating and/or imaging a brain tissue are also known.
Document WO2016202955 describes a detection apparatus for imaging at least two areas of a brain of a subject. The detection apparatus comprises a support including a frame intended to be attached to the skull of the subject, the frame delimiting an inner portion which is transparent to the ultrasonic waves. The detection apparatus also comprises a removable imaging device including a platform, an ultrasonic probe, a movable plate supporting the ultrasonic probe, and a fastener intended to cooperate with three pins of the support to temporarily lock the plateform to the support. However such an apparatus is not implantable under the skin of the subject's skull.
Document US2014/0330123 describes a sonic window adapted to close an opening formed in the skull of a patient. The sonic window comprises an outer surface and an inner surface each including holes. However, such a sonic window is difficult to locate once implanted and covered with the skin of the subject's skull.
Document US2015/0321026 describes a device for regulating the focal depth of an ultrasonic energy emitted for treating or imaging a tissue. The regulation device comprises an ultrasonic transducer and a spacer intended to be positioned between the ultrasonic transducer and the patient's skin. Elements may be provided in the spacer, these elements having an acoustic impedance different from that of the spacer to favor or block the passage of the ultrasonic waves. However, such a regulation device is not implantable.
An object of the present invention is to propose an assembly for imaging and/or treating a brain tissue by ultrasounds making it possible to overcome at least one of the aforementioned disadvantages.
For this purpose, the invention proposes an assembly for imaging and/or treating a brain tissue comprising:
Document WO2016202955 does not describe an assembly in which the acoustic window is intended to be covered with skin once implanted. Furthermore, document WO2016202955 does not describe an assembly in which the acoustic window comprises a positioning mark locatable through the skin of the patient's skull. Indeed, the three pins of the support do not constitute positioning marks. On the contrary, these pins form, with the element for attaching the platform, means for locking temporarily the platform 16 on the frame 14. Moreover, no positioning mark is necessary in the detection apparatus according to document WO2016202955 since the window is not intended to be implanted under the skin of the skull of the subject to be treated.
Document US2014/0330123 does not describe an assembly in which an acoustic window comprises a positioning mark locatable through the skin of the patient's skull. On the contrary, in document US2014/0330123, the holes constitute, with the anchoring elements, means for attaching the sonic window in the opening formed through the skull of the patient.
Document US2015/0321026 does not describe an assembly in which the acoustic window is intended to be covered with skin once implanted. Furthermore, Document US2015/0321026 does not describe an acoustic window including one (or more) positioning mark(s) locatable through the skin of the patient's skull. On the contrary, in document US2015/0321026, the spacer (including the elements of acoustic impedance different from that of the spacer) is intended to be positioned on the skin. Furthermore, document US2015/0321026 does not teach those skilled in the art that the integration of a positioning mark locatable through the skin of the skull—such as a marker visible by ultrasonography—to an implantable window can favor its detection once it is implanted (and covered with the skin of the patient's skull).
Preferred but non-limiting aspects of the present invention are as follows:
Other advantages and characteristics of the assembly for imaging and/or treating a brain tissue will become more apparent from the following description of several variants, given by way of non-limiting examples, from the appended drawings in which:
Various examples of assemblies for imaging and/or treating a brain tissue with reference to
1. General Principle
The assembly for imaging and/or treating a brain tissue comprises:
This assembly allows a practitioner to check the progression of a brain tissue by imaging and/or to treat the brain tissue by using ultrasounds.
The probe is intended to be handled by the practitioner. It comprises a casing in which is housed at least one transducer (not represented) for the generation of ultrasonic waves.
The window 10 is intended to be implanted into the patient, in particular at an opening arranged in his cranium 4. This provides a protection to the brain and prevents its deformation due to pressure changes.
In the following, the window 10 and the probe will be described in more detail with reference to
2. Acoustic Window
The window 10 comprises a plate 1 and one (or more) positioning mark(s) 2 for detecting the center of the plate 1 once the window 10 is implanted.
2.1. Plate
The plate 1 may be substantially flat. Alternatively, the plate 1 may be curved to follow the curvature of the cranium 4 of the patient. In particular, the plate can be made by three-dimensional printing, its shape being provided to follow the curvature of the patient's skull.
The plate 1 is advantageously made of an acoustically transparent material to enables the passage of the ultrasonic waves through the window 10 in order to image and/or treat a brain tissue.
The material chosen to constitute the plate 1 has preferably a low acoustic absorption to limit the heating of the window 10 during the emission of ultrasonic waves by the probe. Indeed, during the passage of the ultrasonic waves through the window 10, a portion of the energy is absorbed by the plate 1. This absorbed energy is converted into heat. By choosing a material having a low acoustic absorption to constitute the plate 1, the risks of heating of the window 10 and therefore burning of the patient are limited.
The material chosen to constitute the plate 1 further has preferably an acoustic impedance close to 1.5 Mega-Rayleigh to limit the reflections of the acoustic wave on the window. By choosing a material having an acoustic impedance close to 1.5 Mega-Rayleigh to constitute the plate 1, it is made sure that all the acoustic energy emitted by the probe enters the window and, if the latter is not very absorbent, the brain tissue.
Preferably, the material chosen to constitute the plate 1 is rigid, non-brittle and has a high thermal conductivity (to favor the evacuation of heat generated during the passage of the ultrasonic waves through the window 10 and in the brain tissue).
For example, the material can be:
The plate 1 is generally rectangular, but it should be noted that the plate 1 may have any shape, such as a circular shape. The dimensions of the plate 1 (length and width) can be comprised between 1 and 15 centimeters. In particular, the dimensions of the acoustic window may vary depending on the depth of the brain tissue (in particular a tumor) to be treated or imaged. For example, in the case of a deep tumor, the dimensions of the acoustic window may be smaller than the dimensions of the tumor, whereas in the case of a superficial tumor (i.e. close to the cranium), the dimensions of the window will be preferably equal to (or greater than) the dimensions of the tumor.
Indeed, in the case of a deep tumor, it is possible to treat the entire tumor from an acoustic window (of smaller dimensions than the tumor) by varying the orientation of the probe. Thus, in the case of a deep tumor, it is possible to treat the entire surface of the tumor by emitting ultrasonic waves at different angles of incidence. Advantageously, the acoustic window will be chosen as small as possible by taking into account the dimensions of the area to be treated, its depth and the possibility of inclining the emission of the ultrasounds with respect to the window.
Advantageously, the thickness “e” of the plate 1 is chosen equal to an integer multiple of half the wavelength in the plate 1, of the ultrasonic waves generated by the probe. This makes it possible to improve the coefficient of transmission of the ultrasonic waves in the plate 1, even in the event of significant impedance mismatch between the impedance of the material constituting the plate 1 and the external environment.
In some variants, the plate 1 is composed of a superposition of layers of different materials transparent to the ultrasonic waves. For example, in one variant, the plate 1 is composed of a rigid material layer extending between two flexible material layers:
The window may also comprise one (or more) acoustic impedance matching layer(s). The acoustic impedance matching layer(s) is/are made of a material—such as parylene or silicone—whose acoustic impedance is comprised between the impedance of the transducers of the probe and the acoustic impedance of the target area. The presence of matching layers makes it possible to limit the reflections of ultrasonic waves at the interface between the transducer 21 and the acoustic window and between the window and the tissue. If the window is made of a relatively “heavy” and thick material to be mechanically solid (for example epoxy, or even ceramic) and if the reflection coefficient is high, to limit the reflection, it is possible to add a layer (or two, one on each side) of a quarter of the wavelength of thickness, and ideally of impedance (Zplate×Zwater){circumflex over ( )}0.5 according to the well-known formula. This material may for example be a silicone (if the plate is made of epoxy) or made of epoxy (if the plate is made of ceramic or metal). More generally, it is possible to optimize a multilayer structure to have a low reflection coefficient and good mechanical rigidity by choosing the appropriate thicknesses and materials. Another solution is to use an exactly thick window of the wavelength divided by 2 without a quarter-wave plate.
The window 10 may also comprise reinforcements for increasing the mechanical strength of the plate 1. The reinforcements extend for example at the edges of the plate 1.
The reinforcements may consist of rods made of rigid material—such as titanium or stainless steel or any other biocompatible metal known to those skilled in the art—integrated in the plate 1.
Alternatively, the reinforcements may be made of the same material as the plate 1. For example, the reinforcements may consist of one (or more) peripheral area(s) of the plate 1 having a thickness/thicknesses greater than the thickness of a central area of the plate 1. Thus, the plate can comprise thick areas for reinforcing its mechanical strength and thinned areas for a better transmission of the ultrasonic waves.
Different solutions can be adopted for the implantation of the plate 1 previously described into the skull of the patient. In particular, the plate 1 can be implanted:
In the embodiment illustrated in
The window 10 illustrated in
As illustrated in
2.1.2. Second Variant of Implantation of the Acoustic Window
Alternatively, the acoustic window may be adapted to cover the opening while extending above the cranium of the patient (see
In this variant, the acoustic window comprises through holes 13 arranged between the upper 11 and lower 12 faces of the plate 1. These holes 13 extend at the periphery of the plate 1, along each edge of the plate. The holes 13 are intended to receive attachment elements—such as bone anchoring screws—for attaching the window 10 on the cranium 4.
In this variant of implantation and as illustrated in
This embodiment allows reducing the constraints for the practitioner in making the opening arranged in the cranium. Indeed, the practitioner does no longer have to make an opening at dimensions and shape very accurate with respect to the dimensions and shape of the plate 1.
2.2. Positioning Mark(s)
The window 10 also comprises one (or more) positioning mark(s) 2. The positioning mark(s) allow(s) the practitioner to identify the position of the plate 1 and thus to position the probe in line with said plate 1 in order to image and/or treat an underlying brain tissue. The use of positioning marks makes it possible to reduce the time required to implement a session for imaging and/or treating the cerebral area, in particular with respect to a solution based on the use of a neuro-navigation assembly.
Indeed, without this positioning mark 2, it would be difficult for the practitioner to accurately identify the position of the window 10 once the latter is implanted, the window 10 being covered with the skin 3 of the patient's skull. However, the knowledge of the accurate position of the window 10 is necessary to ensure proper positioning of the probe above the plate 1.
As will be described in more detail below, each positioning mark may consist of:
The choice among these different types of positioning marks is independent of the variant of implantation chosen for the acoustic window (i.e. acoustic window extending in the extension of the cranium or above the cranium). Moreover, these different types of positioning mark can be used in combination in the same acoustic window 10.
Advantageously, when the window comprises several positioning marks disposed on a plate, these can all be different. This facilitates the repeatability of the positioning and orientation of the probe during successive sessions for imaging and/or treating a brain tissue.
2.2.1. First Example of a Positioning Mark
In the embodiment illustrated in
Referring to
Alternatively, the window 10 may comprise several pins (in particular two, three, four, etc.). For example, the window 10 may comprise four pins 2 disposed in the vicinity of the corners of the rectangular plate 1 on the upper surface 11 of the plate.
Of course, the shape and dimensions of the mechanical positioning mark may vary depending on the application. For example, the positioning mark may consist of a crater whose peripheral edges extend outwardly of the plate and whose central region is hollowed out within the thickness of the plate.
2.2.2. Second Example of a Positioning Mark
In this embodiment, the window 10 comprises centering markers 2a, 2b, 2c, 2d (respectively 21 to 24 and 25 to 27) visible by ultrasounds, optics or MRI.
In the variants illustrated in
In the variant illustrated in
The use of centering markers makes it possible to have markers integrated into the plate 1 without protrusion on the upper face 11 of the plate 1.
These centering markers are for example detectable by using the transducers of the imaging and/or treatment probe in A-mode ultrasonography (also called “A-scan” or “A-mode”). The A-mode ultrasonography is based on the emission of an acoustic information and the reception of echoes along a propagation line. Alternatively, the probe may comprise specific transceivers (operating in A-mode) enabling the detection of the centering markers.
Once the position of the centering markers is detected using the probe, the latter can be positioned accurately above the window 10 prior to the application of ultrasonic waves to image or treat a brain tissue.
The markers detectable by ultrasounds or by optics can coexist with markers detectable by MRI. Advantageously, the first ones are in a known geometric relationship with the second ones.
In the embodiment illustrated in
Alternatively, the centering markers detectable by ultrasounds, optics or MRI may all be different, as illustrated in
More precisely in the embodiment illustrated in
In the embodiment illustrated in
Even if one-millimeter variations between the different blind holes are difficult to identify by touch, they can be detected by using the transducers of the probe in A-mode ultrasonography, these recording the waves reflected by the blind holes at different times (see
The embodiments illustrated in
2.2.3. Modes of Detection of the Centering Markers Illustrated in
When using the probe in A-mode ultrasonography, the reflected waves OR1, OR2, OR3, OR4 by the elements 213, 223, 233, 243 are recorded by the probe at different times t1, t2, t3, t4 relative to the times of recording the waves reflected by the first and second reflectors 211, 221, 231, 241 and 212, 222, 232, 242.
Thus, it is possible to distinguish the different markers 21, 22, 23, 24 when the practitioner searches the position of the window 10. This facilitates the introduction of the probe in line with the window 10.
When using the probe in A-mode ultrasonography, the reflected waves ORa, ORb, ORc by the bottoms 251, 261, 271 of the blind holes are recorded by the probe at different times ta, tb, tc relative to the times of recording the waves reflected by the rear face of the plate.
Thus, it is possible to distinguish the different markers 25, 26, 27 when the practitioner searches the position of the window 10 in order to facilitate the introduction of the probe to perform the treatment.
3. Operating Principle
The operating principle of the assembly for imaging and/or treating a brain tissue will be now described with reference to
In a first step, the practitioner implants (step 100) the window 10 into the skull of the patient. He makes one (or more) opening(s) in the skull of the patient, and attaches a window 10 in the opening (or in each respective opening) by gluing or anchoring. When implanting the window, the practitioner can fill the free space between the window 10 and the dura mater with a suitable material (gel or saline solution). The practitioner then covers the window with the skin 3 of the patient. Advantageously, the incision of the patient's skin is practiced so as to prevent the scar resulting from the closuring of the skin after implantation of the window from covering the window (the quality of ultrasonic wave transmission being reduced through the scars).
Once the window is implanted, a succession of sessions for imaging and/or treating a brain tissue can be provided to the patient.
At each new treatment session, the practitioner implements a step of detecting (step 200) the position of the window 10. It switches the probe into a location mode (transducers of the probe or specific transceivers activated in A-mode ultrasonography), applies a transmission gel for ultrasonography on the patient's hair, and displaces the probe over the patient's skull to detect the position of the window 10.
When the probe detects one of the centering markers 21, 22, 23, 24, a processing unit connected to the probe sends information to inform to the practitioner that a centering marker has been detected.
Since the markers are all different, the processing unit can define which of the centering markers has been detected and provide information to the practitioner on the direction in which it is preferable to displace the probe to detect the other three centering markers. For example, if the detected centering marker is the marker disposed in the upper left corner of the window 10, the processing unit instructs the practitioner to displace the probe in a downward and rightward direction.
When the four centering markers are detected, the processing unit sends information to the practitioner asking him to hold the probe stationary. Optionally, the probe may be removed to reapply transmission gel on the patient's hair above the window before repositioning (step 300) the probe in line with the window 10.
Once the probe is positioned, the practitioner switches the mode of operation of the probe from the location mode to a treatment or imaging mode. The transducers are activated to allow imaging or treating the brain tissue (step 400).
The reader will have understood that many modifications can be made to the invention described above without physically departing from the new teachings and advantages described herein.
For example, in the foregoing description, the positioning marks were:
Of course, each positioning mark could consist of an element locatable by touch and detectable and by ultrasounds and/or MRI. Moreover, one (or more) positioning mark(s) detectable by ultrasounds or MRI may be combined with one or more mechanical element(s) locatable by touch or by optics within the same acoustic window.
Accordingly, any modifications of this type are intended to be incorporated within the scope of the attached claims.
| Number | Date | Country | Kind |
|---|---|---|---|
| 1755562 | Jun 2017 | FR | national |
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/EP2018/066203 | 6/19/2018 | WO |
| Publishing Document | Publishing Date | Country | Kind |
|---|---|---|---|
| WO2018/234280 | 12/27/2018 | WO | A |
| Number | Name | Date | Kind |
|---|---|---|---|
| 4348289 | Snavely et al. | Sep 1982 | A |
| 4530358 | Forssmann et al. | Jul 1985 | A |
| 5246595 | Bourlion et al. | Sep 1993 | A |
| 5394875 | Lewis | Mar 1995 | A |
| 5549620 | Bremer | Aug 1996 | A |
| 6350284 | Tormala | Feb 2002 | B1 |
| 9044195 | Manwaring et al. | Jun 2015 | B2 |
| 9440064 | Wingeier | Sep 2016 | B2 |
| 10952701 | Deffieux | Mar 2021 | B2 |
| 20050165312 | Knowles et al. | Jul 2005 | A1 |
| 20070173844 | Ralph | Jul 2007 | A1 |
| 20070260140 | Solar | Nov 2007 | A1 |
| 20090227830 | Pillutla et al. | Sep 2009 | A1 |
| 20100143241 | Johnson et al. | Jun 2010 | A1 |
| 20100217160 | Saguchi et al. | Aug 2010 | A1 |
| 20110312891 | Gestrelius | Dec 2011 | A1 |
| 20120209150 | Zeng et al. | Aug 2012 | A1 |
| 20130289411 | Barnard et al. | Oct 2013 | A1 |
| 20140330123 | Manwaring | Nov 2014 | A1 |
| 20150321026 | Branson | Nov 2015 | A1 |
| 20150360058 | Barthe | Dec 2015 | A1 |
| 20170086785 | Bjaerum | Mar 2017 | A1 |
| 20170209274 | Beerens | Jul 2017 | A1 |
| 20190184204 | Ramamurthy | Jun 2019 | A1 |
| Number | Date | Country |
|---|---|---|
| 2539021 | Feb 2016 | EP |
| 3020450 | May 2016 | EP |
| 2010104656 | May 2010 | JP |
| 2017074293 | Apr 2017 | JP |
| 8907907 | Sep 1989 | WO |
| 9314712 | Aug 1993 | WO |
| WO-2007056734 | May 2007 | WO |
| 2007064453 | Jun 2007 | WO |
| 2014179720 | Nov 2014 | WO |
| WO-2016012376 | Jan 2016 | WO |
| 2016202955 | Dec 2016 | WO |
| Entry |
|---|
| https://www.rshydro.co.uk/sound-speeds/ RS Hydro, “Sound Speeds in Water, Liquid, and Materials”, Sep. 2015 (Year: 2015). |
| Lucas VS, Burk RS, Creehan S, Grap MJ. Utility of high-frequency ultrasound: moving beyond the surface to detect changes in skin integrity. Plast Surg Nurs. Jan.-Mar. 2014; 34(1):34-8. doi: 10.1097/PSN.0000000000000031. PMID: 24583666; PMCID: PMC4027962. (Year: 2014). |
| Ingraham CR, Mannelli L, Robinson JD, Linnau KF. Radiology of foreign bodies: how do we image them? Emerg Radiol. Aug. 2015; 22(4):425-30. doi: 10.1007/s10140-015-1294-9. Epub Feb. 4, 2015. PMID: 25648360 (Year: 2015). |
| Amstutz C, Caversaccio M, Kowal J, Bächler R, Nolte LP, Häusler R, Styner M. A-mode ultrasound-based registration in computer-aided surgery of the skull. Arch Otolaryngol Head Neck Surg. Dec. 2003 (Year: 2003). |
| Bing et al., “Blood-Brain Barrier (BBB) Disruption Using a Diagnostic Ultrasound Scanner and Definity® in Mice”, Ultrasound Med. Biol., vol. 35, No. 8, pp. 1298-1308, 2009. |
| Carpentier et al., “Clinical trial of blood-brain barrier disruption by pulsed ultrasound”, ScienceTranslationalMedicine, vol. 8, No. 343, 2016. |
| Eames et al., “Trans-cranial focused ultrasound without hair shaving: feasibility study in an ex vivo cadaver model”, Journal of Therapeutic ultrasound, vol. 1, No. 24, 2013. |
| Guess et al., “Acoustic properties of some biocompatible polymers at body temperature”, Ultrasound Med. & Biol., vol. 21, No. 2, pp. 273-277, 1995. |
| Hynynen et al., “Noninvasive MR Imaging-guided Focal Opening of the Blood-Brain Barrier in Rabbits”, Radiology, vol. 220, N. 3, pp. 640-646, 2001. |
| Marquet et al., “Noninvasive, Transient and Selective Blood-Brain Barrier Opening in Non-Human Primates In Vivo” PLOS One, vol. 6, No. 7, 2011. |
| McDannold et al., “Temporary Disruption of the Blood-Brain Barrier by Use of Ultrasound and Microbubbles: Safety and Efficacy Evaluation in Rhesus Macaques”, Cancer Res., vol. 72, No. 14, pp. 3652-3663, 2012. |
| Melamed et al., “Sonographic Appearance of Oxidized Cellulose (Surgicel): Pitfall in the Diagnosis of Postoperative Abscess”, J. Ultrasound Med., vol. 14, No. 1, pp. 27-30, Jan. 1995. |
| Raymond et al., “Acoustic Transmission Losses and Field Alterations Due to Human Scalp Hair”, IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control, vol. 52, No. 8, pp. 1415-1419, Aug. 2005. |
| Sparing et al., “Transcranial Magnetic Stimulation and the Challenge of Coil Placement: A Comparison of Conventional and Stereotaxic Neuronavigational Strategies”, Human Brain Mapping, vol. 29, No. 1, pp. 82-96, Jan. 2008. |
| Tobias et al., “An ultrasound window to perform scanned, focused ultrasound hyperthermia treatments of brain tumors”, Medical Physics, vol. 14, No. 2. pp. 228-234, 1987. |
| Van der Bom et al., “Frameless multimodal image guidance of localized convection-enhanced delivery of therapeutics In the brain”, J. Neurointerv. Surg., vol. 5, No. 1, pp. 69-72, Jan. 2013. |
| Wei et al., “Neuronavigation-Guided Focused Ultrasound-Induced Clood-Brain Barrier Opening: A Preliminary Study in Swine”, AJNR. Am. J. Neuroradiol., vol. 34, No. 1, pp. 115-120, Jan. 2013. |
| Number | Date | Country | |
|---|---|---|---|
| 20200138580 A1 | May 2020 | US |
